**Core Concept**
Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to cholestasis and ultimately cirrhosis. The exact pathogenesis of PBC is not fully understood, but it is believed to involve a complex interplay between genetic predisposition, environmental triggers, and immune system dysregulation.

**Why the Correct Answer is Right**
PBC is not a disease characterized by the presence of anti-smooth muscle antibodies (ASMA). While ASMA are often found in patients with autoimmune hepatitis, they are not typically associated with PBC. In contrast, PBC is often associated with the presence of antimitochondrial antibodies (AMA), which are thought to play a key role in the disease's pathogenesis. The AMA targets the E2 subunit of the pyruvate dehydrogenase complex, leading to mitochondrial dysfunction and bile duct damage.

**Why Each Wrong Option is Incorrect**
**Option A:** PBC is indeed a disease characterized by the progressive destruction of intrahepatic bile ducts, which is not true about autoimmune hepatitis. However, PBC is also associated with the destruction of intrahepatic bile ducts.
**Option B:** PBC is not a disease characterized by the presence of ASMA, making this statement true about PBC.
**Option C:** PBC is indeed a disease characterized by the presence of AMA, which is a hallmark of the disease.

**Clinical Pearl / High-Yield Fact**
One important clinical correlation to remember is that PBC is often associated with other autoimmune diseases, such as Sjögren's syndrome and thyroid disease. Patients with PBC should be screened for these conditions and managed accordingly.

**Correct Answer: B. PBC is not a disease characterized by the presence of anti-smooth muscle antibodies (ASMA).**